Detection of Phrenic Nerve Stimulation Using Sensors' Signals
Completed
- Conditions
- Heart Failure
- Registration Number
- NCT01233323
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
The purpose of this study is to collect sensor data from patients with implanted cardiac resynchronization devices who exhibit phrenic nerve stimulation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Willing and capable of providing informed consent and of participating in all testing
- Age 18 or above or of legal age to give informed consent specific to national law
- Implanted with a Boston Scientific COGNIS™ family device
- Geographically stable and is available for follow-up procedures at a study centre
Exclusion Criteria
- Patients that are pacemaker-dependent
- Women who are pregnant or plan to become pregnant during the study (method of assessment upon physician's discretion)
- Patients who are currently enrolled in another investigational study or registry that would directly interfere with the current study, except when the patient is participating in a mandatory governmental registry
- Patients who are not expected to support approximately 30 minutes of study testing procedures
- Patients who are not mentally competent enough to provide feedback on PS during study procedures
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Data collection 3 months follow up Collect sensor data in patients with implanted CRT-D devices who exhibit phrenic nerve stimulation.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link phrenic nerve stimulation to cardiac resynchronization therapy in heart failure patients?
How does sensor-based detection of phrenic nerve stimulation compare to traditional clinical monitoring in CRT device users?
Which biomarkers predict phrenic nerve stimulation risk in heart failure patients with implanted cardiac devices?
What adverse events are associated with phrenic nerve stimulation in CRT patients, and how are they managed?
What sensor technologies do competitors like Medtronic use for phrenic nerve stimulation detection in heart failure management?
Trial Locations
- Locations (1)
Deutsches Herzzentrum Berlin
🇩🇪Berlin, Germany
Deutsches Herzzentrum Berlin🇩🇪Berlin, Germany